RxSight is the global leader in adjustable intraocular lens technology. The company's revolutionary intraocular lens (IOL) is the first and only FDA approved IOL that can be adjusted after cataract surgery to improve uncorrected visual acuity and reduce astigmatism.
Using a proprietary light treatment that produces precise modifications in lens curvature, RxSight's Light Adjustable Lens (RxLAL) enables doctors and patients to predictably optimize vision after cataract surgery through an office based IOL enhancement.